Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.
Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy / Speight, J., Hussain, S., Anandhakrishnan, A., Danne, T., Latres, E., Karpen, S.R., Mytkolli, L., Scibilia, R., Soeholm, U., Senior, P.A., Vallis, M., De Wit, M., Read, M., Press, C., Pokerznik, M.A., Piemonti, L., Nutt, D., Mcleod, H., Marinac, M., Lally, J., et al.. - In: NATURE MEDICINE. - ISSN 1078-8956. - 32:3(2026), pp. 797-801. [10.1038/s41591-026-04201-3]
Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy
Piemonti L.;
2026-01-01
Abstract
Stem-cell-derived islet cells could transform type 1 diabetes by removing the need for injected or infused insulin and improving quality of life. But evaluation of these therapies must center on the voices of people living with type 1 diabetes and examine meaningful outcomes.| File | Dimensione | Formato | |
|---|---|---|---|
|
s41591-026-04201-3.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
750.54 kB
Formato
Adobe PDF
|
750.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
